Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival

Saved in:
Bibliographic Details
Published in:Anti-cancer drugs Vol. 26; no. 8; pp. 910 - 911
Main Authors: Francini, Edoardo, Fiaschi, Anna I, Petrioli, Roberto, Bianco, Vincenzo, Laera, Letizia, Francini, Filippo, Roviello, Giandomenico
Format: Journal Article
Language:English
Published: England Copyright Wolters Kluwer Health, Inc. All rights reserved 01-09-2015
Subjects:
Adult
Aged
Aged, 80 and over
Androstenes - adverse effects
Androstenes - therapeutic use
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Humans
Male
Middle Aged
Neoplasm Metastasis
Prostatic Neoplasms, Castration-Resistant - drug therapy
Prostatic Neoplasms, Castration-Resistant - mortality
Prostatic Neoplasms, Castration-Resistant - pathology
Survival Analysis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0959-4973
1473-5741
DOI:10.1097/CAD.0000000000000258